HC Wainwright & Co. Maintains Buy on Mind Medicine, Lowers Price Target to $35

HC Wainwright & Co. analyst Patrick Trucchio maintains Mind Medicine (NASDAQ:MNMD) with a Buy and lowers the price target from $75 to $35.

BenzingaMay 10 15:39 ET

Mind Medicine Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 280.43% HC Wainwright & Co. $75 → $35 Maintains Buy 04/15/2024 117.39% Leerink Partners → $20 I

BenzingaMay 10 15:37 ET

Unpacking the Latest Options Trading Trends in AppLovin

Investors with a lot of money to spend have taken a bullish stance on AppLovin (NASDAQ:APP).And retail traders should know.We noticed this today when the positions showed up on publicly available opti

BenzingaMay 10 12:19 ET

Vital Farms Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 6.1% Stifel $30 → $40 Downgrades Buy → Hold 04/26/2024 -20.42% Stifel $22 → $30 Maintains Buy 0

BenzingaMay 10 05:33 ET

Vistra Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 19.54% UBS $85 → $110 Maintains Buy 04/18/2024 -10.89% Janney Montgomery Scott → $82 Initiates

BenzingaMay 9 14:38 ET

Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Duolingo, Inc. (NASDAQ:DUOL) fell sharply during Thursday's session after the company reported first quarter financial results.Duolingo reported quarterly earnings of 57 cents per share whic

BenzingaMay 9 13:57 ET